These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Effectiveness of non-starch polysaccharide crylan in experimental hyperlipidemia]. Remezova OV; Okunevich IV; Vitovskaia GA; Anan'eva EP; Ryzhenkov VE Vopr Pitan; 1995; (2):14-6. PubMed ID: 7483461 [TBL] [Abstract][Full Text] [Related]
6. [Hypolipidemic, hypocholesterolemic and antisclerotic action of the rotenoid glycoside amorphin]. Kurmukov AG; Aĭzikov MI; Rasulova SA; Makhmudov OKh Farmakol Toksikol; 1986; 49(6):54-7. PubMed ID: 3817147 [TBL] [Abstract][Full Text] [Related]
7. [Lipid depression by etofibrate in a comparative study in rats with artificial hyperlipidemia]. Sterner W; Schultz A Arzneimittelforschung; 1974 Dec; 24(12):1990-2. PubMed ID: 4480360 [No Abstract] [Full Text] [Related]
9. [Evaluation of the antilipaemic potential of etofylline clofibrate, its metabolites and clofibrate in dietary-induced hyperlipidaemia in the rat (author's transl)]. Sterner W; Chibanguza G; Metz G Arzneimittelforschung; 1980; 30(11b):2038-41. PubMed ID: 7194056 [TBL] [Abstract][Full Text] [Related]
10. [Hypolipidemic activity of glycine and its derivatives]. Ryzhenkov VE; Molokovskiĭ DS; Ioffe DV Vopr Med Khim; 1984; 30(2):78-80. PubMed ID: 6740998 [TBL] [Abstract][Full Text] [Related]
11. [Experimental hypolipidemic and antiatherosclerotic activity of bisanions]. Ryzhenkov VE; Khromov-Borisov NV; Mosina IV; Indenbom ML Farmakol Toksikol; 1979; 42(6):632-5. PubMed ID: 499472 [TBL] [Abstract][Full Text] [Related]
12. [The hypolipidemic action of water-soluble enterosorbents of cholesterol and bile acids in an experiment]. Chistiakova AM; Frolova IuV; Triufanov VF; Vasil'eva LE; Lozovskiĭ VT; Ryzhenkov VE Eksp Klin Farmakol; 1992; 55(5):41-4. PubMed ID: 1305451 [TBL] [Abstract][Full Text] [Related]
13. Hypolipidemic effects of S-methylmethionine (vitamin U) using various experimental procedures. Seri K; Matsuo T; Taniguchi T; Amemiya K; Kudo M; Saito G; Kato T Arzneimittelforschung; 1980; 30(10):1694-703. PubMed ID: 7192109 [TBL] [Abstract][Full Text] [Related]
14. [Therapy of hyperlipidemia]. Müller G Dtsch Gesundheitsw; 1971 Oct; 26(43):2020-4. PubMed ID: 4947270 [No Abstract] [Full Text] [Related]
15. Effects of polydatin from Polygonum cuspidatum on lipid profile in hyperlipidemic rabbits. Xing WW; Wu JZ; Jia M; Du J; Zhang H; Qin LP Biomed Pharmacother; 2009 Aug; 63(7):457-62. PubMed ID: 18657948 [TBL] [Abstract][Full Text] [Related]
16. Contemporary recommendations for evaluating and treating hyperlipidemia. Perry RS Clin Pharm; 1986 Feb; 5(2):113-27. PubMed ID: 3514084 [TBL] [Abstract][Full Text] [Related]
17. Hypolipidemic effect of Coriandrum sativum L. in triton-induced hyperlipidemic rats. Lal AA; Kumar T; Murthy PB; Pillai KS Indian J Exp Biol; 2004 Sep; 42(9):909-12. PubMed ID: 15462185 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and interactions of oxandrolone, halo-fenate and clofibrate in a factorial study on experimental acute nephrotic hyperlipidemia. Schapel GJ; Edwards KD J Pharmacol Exp Ther; 1975 Jul; 194(1):274-84. PubMed ID: 1171221 [TBL] [Abstract][Full Text] [Related]
19. Aggravation of cholesterol induced hyperlipidemia by chronic vitamin C deficiency: experimental study in guinea pigs. Kothari LK; Sharma P Acta Biol Hung; 1988; 39(1):49-57. PubMed ID: 3254010 [TBL] [Abstract][Full Text] [Related]